Terms: = Endocrine gland cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
10 results:
1. Systematic Pan-cancer Analysis and Experimental Verification Identify foxa1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract] [Full Text] [Related]
2. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.
Gershenson DM; Cobb LP; Westin SN; Zhang Y; Jazaeri A; Malpica A; Sun CC
Gynecol Oncol; 2022 Nov; 167(2):139-145. PubMed ID: 36137845
[TBL] [Abstract] [Full Text] [Related]
3. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract] [Full Text] [Related]
4. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan L; Yang Z; Jiang X; Zhang J; Guo X
Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras
Vilimas T; Wang AQ; Patnaik S; Hughes EA; Singleton MD; Knotts Z; Li D; Frankowski K; Schlomer JJ; Guerin TM; Springer S; Drennan C; Dextras C; Wang C; Gilbert D; Southall N; Ferrer M; Huang S; Kozlov S; Marugan J; Xu X; Rudloff U
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1067-1080. PubMed ID: 30306263
[TBL] [Abstract] [Full Text] [Related]
6. Complex formation and function of estrogen receptor α in transcription requires RIP140.
Rosell M; Nevedomskaya E; Stelloo S; Nautiyal J; Poliandri A; Steel JH; Wessels LF; Carroll JS; Parker MG; Zwart W
Cancer Res; 2014 Oct; 74(19):5469-79. PubMed ID: 25145671
[TBL] [Abstract] [Full Text] [Related]
7. Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1.
Johnson CL; Peat JM; Volante SN; Wang R; McLean CA; Pin CL
J Pathol; 2012 Nov; 228(3):351-65. PubMed ID: 22374815
[TBL] [Abstract] [Full Text] [Related]
8. foxa1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract] [Full Text] [Related]
9. Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors.
Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Kamposioras K; Tountas N; Economopoulos T
Urol Oncol; 2010; 28(6):617-23. PubMed ID: 19110454
[TBL] [Abstract] [Full Text] [Related]
10. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.
Hensley ML; Correa DD; Thaler H; Wilton A; Venkatraman E; Sabbatini P; Chi DS; Dupont J; Spriggs D; Aghajanian C
Gynecol Oncol; 2006 Aug; 102(2):270-7. PubMed ID: 16490239
[TBL] [Abstract] [Full Text] [Related]